SUPN - Supernus Pharmaceuticals GAAP EPS of -$0.02 beats by $0.21 revenue of $135.6M misses by $8.06M
2023-08-08 16:33:58 ET
- Supernus Pharmaceuticals press release ( NASDAQ: SUPN ): Q2 GAAP EPS of -$0.02 beats by $0.21 .
- Revenue of $135.6M (-20.3% Y/Y) misses by $8.06M .
- FY23 Total revenues to be $580M - $620M, vs. $609.65M consensus.
For further details see:
Supernus Pharmaceuticals GAAP EPS of -$0.02 beats by $0.21, revenue of $135.6M misses by $8.06M